Patent Baristas

Whether you are a company conducting diligence or a target being examined, you need to ensure the value of the IP with a thorough and effective IP due diligence review. In this light, the American Conference Institute’s 6th National Conference on Pharma/Biotech IP Due Diligence will be held at the Marriott East Side, New York, […]

As we saw in the Wyeth v. Dudas case, the US District Court for the District of Columbia overturned the USPTO’s interpretation of 35 USC § 154 (the statute that prescribes patent terms). Section 154 grants extensions of patent terms for certain kinds of PTO delay.  However, Congress says you can’t double-dip, i.e., to the […]

On September 30, 2008, the US District Court for the District of Columbia overturned the interpretation of 35 USC § 154 (the statute that prescribes patent terms) by the United States Patent and Trademark Office (PTO).  See Wyeth v. Dudas, No. 07-1492 (D.D.C. September 30, 2008). Section 154(a)(2) establishes a term of 20 years from […]

BNA, the leading provider of expert information and analysis, presents a one-day, information-packed conference entitled Pharmaceutical Patent Law: A Prescription for Success in Challenging Times. The conference will be held at the Ritz-Carlton, Pentagon City, 1250 South Hayes Street, Arlington, VA, on November 12, 2008. BNA offers a prescription for success as legislative, judicial, administrative, […]

Today the PTO published a notice in the Federal Register inviting public comments on paperwork burdens associated with the Ex parte Appeal Rule (73 Fed. Reg. 32937-32977, June 10, 2008).  This Information Collection Request (ICR)  an application from an agency to OMB for OMB’s approval under Paperwork Reduction Act, giving the agency authority to collect information […]

The Biotechnology Institute is now accepting applications for “BioNOW” (Biotechnology Network of Women,) a leadership training program for women biotechnology professionals. The Biotechnology Institute is partnering with biopharmaceutical company Nektar Therapeutics for the program. BioNOW, which will be held December 4-5 at Nektar’s headquarters in San Carlos, CA, will allow participants to develop skills that […]

This summer I went on vacation for a few days to get away from the office, computers, and patent law.  Yet I couldn’t help but to bring a little work with me.  Only this time it wasn’t something I could bill a few hours for; it was the thriller Undue Diligence written by Paul Haughey, […]

Earlier, Dr. Triantafyllos Tafas’ lawsuit, arguing that the proposed U.S. Patent Office continuation rules are void for exceeding its authority, won a permanent injunction prohibiting the USPTO from putting the new rules changes into effect (Final Rules; 72 Federal Register 161 at 46716).  Tafas v. Dudas and the United States Patent and Trademark Office. Dr. […]